Clinical Trial Associate (or Senior)
BioAge Labs
Clinical Trial Associate (or Senior)
BioAge Labs
Clinical-stage biotech developing aging-targeted therapeutics
BioAge Labs (BIOA) is finding new ways to treat disease by targeting the mechanisms of aging, with the ultimate goal of increasing healthy human lifespan.https://bioagelabs.com
BioAge Labs (BIOA) is finding new ways to treat disease by targeting the mechanisms of aging, with the ultimate goal of increasing healthy human lifespan. https://bioagelabs.com
BioAge is seeking a Clinical Trial Associate (Senior CTA) to join our Clinical Operations team.
The CTA plays a critical role in the execution of Phase 1–3 clinical trials and is responsible for ensuring operational excellence, inspection readiness, and compliance with ICH/GCP guidelines and company SOPs. This position partners closely with Clinical Trial Managers, CROs, vendors, and investigative sites to support timely and high-quality study delivery.
Our company
BioAge is a clinical-stage biopharmaceutical company harnessing the biology of human aging to develop new therapies for metabolic diseases. The Company’s human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify molecular pathways that drive metabolic aging and disease. BioAge’s lead program, BGE-102, is a potent, orally available, brain-penetrant NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases. The Company is also advancing oral and injectable APJ agonists—exercise mimetics with the potential to enhance incretin-driven weight loss and restore healthy body composition in obesity. BioAge’s discovery platform is validated by ongoing research collaborations with Novartis and Lilly. BioAge has been listed on Nasdaq (BIOA) since 2024. For additional information about BioAge, visit the company’s website athttps://bioagelabs.com.
Our workplace
BioAge offers competitive salary, a comprehensive compensation package, and generous paid time off in addition to company-observed holidays. We provide comprehensive health and wellness benefits (medical, dental, and vision insurance) and a 401(k) retirement savings plan with matching employer contributions, and we support families through childcare and fertility benefits. We also pride ourselves in giving employees many opportunities for career development, including a generous annual budget for continued learning and a dedication to training and skill development. Many positions (including this one) are remote, allowing our team members to work from anywhere. The salary for this role is expected to be approximately $80,000 - 90,000, depending on experience. We are open to the concept that different experience levels add value to the team in different ways, and therefore will consider a variety of experience and offer commensurate pay.
At BioAge, we embrace diversity and differences while we learn from each other, and we believe that every team member has an important role to play. We are an equal opportunity employer. BioAge prohibits discrimination and harassment of any type and affords equal employment opportunities to employees and applicants without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law. BioAge conforms to the spirit as well as to the letter of all applicable laws and regulations.
[]
Clinical-stage biotech developing aging-targeted therapeutics
BioAge Labs develops therapies for age-related diseases by using a human-first discovery platform that maps human aging and translates those insights into a portfolio of drugs. Its approach starts from human aging profiles to identify drug targets and then creates medicines that prevent or treat diseases of aging, with the aim of extending healthy lifespan. The company operates in the clinical stage, developing longevity-focused therapeutics that can be sold to healthcare providers and patients as they progress through trials and gain approvals. What sets BioAge Labs apart is its focus on human aging biology as the starting point for drug development and its goal to address aging itself, not just individual diseases, providing a path to broader healthspan extension compared to traditional disease-focused approaches. The overarching goal is to deliver longevity medicine that delays or prevents age-related decline and improves healthspan for patients.
Explore more opportunities at BioAge Labs